Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Annals of Surgical Oncology|December 9, 2024
ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Irradiation Is AdministeredNeslihan Cabioglu, Hasan Karanlik, Abdullah Igci, et al.Journal of Clinical Medicine|June 26, 2025
Predicting the Unexpected: Clinicopathological Insights into Skip Metastasis in Papillary Thyroid CarcinomaIbrahim Burak Bahcecioglu, Adile Begum Bahcecioglu, Sevket Baris Morkavuk, et al.Asian Journal of Surgery|August 20, 2024
The use of incisional negative pressure wound therapy on high-risk breast cancer mastectomy patientsEbru Esen, Sevket Baris Morkavuk, Mujdat Turan, et al.Breast Cancer (Tokyo, Japan)|August 29, 2015
How do surgeons approach breast cancer surgery in Turkey? A national surveyMustafa Emiroğlu, Abdullah Inal, İsmail Sert, et al.Medicina (Kaunas, Lithuania)|March 28, 2026
Alterations in PD-L1+ Myeloid Cells and Immune Infiltration Are Associated with Atezolizumab and Paclitaxel Therapy Success in a Triple-Negative Breast Cancer ModelKerim Bora Yilmaz, Ece Tavukcuoglu, Hamdullah Yanik, et al.Medicina (Kaunas, Lithuania)|July 30, 2025
CD66b+ Tumor-Infiltrating Neutrophil-like Monocytes as Potential Biomarkers for Clinical Decision-Making in Thyroid CancerHamdullah Yanik, Ilgin Demir, Ertugrul Celik, et al.Annals of Surgical Oncology|February 3, 2021
The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry StudyAtilla Soran, Lutfi Dogan, Arda Isik, et al.Current Oncology (Toronto, Ont.)|October 28, 2025
Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1aAtilla Soran, Berk Göktepe, Berkay Demirors, et al.Cancer|October 30, 2024
Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is providedMahmut Muslumanoglu, Neslihan Cabioglu, Abdullah Igci, et al.Annals of Surgical Oncology|December 2, 2024
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03Neslihan Cabioglu, Hasan Karanlik, Abdullah Igci, et al.Pageof 5